ADAMS Street Partners LLC, 10% Owner at Fusion Pharmaceuticals Inc. (FUSN), sold 4,569 shares at $12.39 ($57K) on 2020-12-23, disclosed to the SEC on 2020-12-28.
Open-market sale of $57k FUSN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.39 | 547 | $7K | 12.0% |
| 2 | $12.39 | 564 | $7K | 12.3% |
| 3 | $12.39 | 734 | $9K | 16.1% |
| 4 | $12.39 | 819 | $10K | 17.9% |
| 5 | $12.39 | 1,905 | $24K | 41.7% |
| Total | $12.39 avg | 4,569 |
| $57K |
| 100% |
| Filing → |
| FUSN | SELL | 2020-12-29 | $47K | — | Filing → |
| APTX | BUY | 2020-01-14 | $3.0M | — | Filing → |
| APTX | BUY | 2018-06-26 | $2.4M | — | Filing → |